Table 1 Baseline characteristics of the study groups
Control | ITM 0.1 mg | ITM 0.2 mg | |
|---|---|---|---|
N=30 | N=30 | N=30 | |
Gender, N (%): Female | 20 (66.7 %) | 18 (60.0 %) | 15 (50.0 %) |
Gender, N (%): Male | 10 (33.3 %) | 12 (40.0 %) | 15 (50.0 %) |
Age (years), M (SD) | 69.4 (6.70) | 63.6 (8.39) | 57.4 (10.4) |
Weight (kg), M (SD) | 73.0 (7.40) | 87.5 (9.10) | 80.0 (9.45) |
Height (cm), M (SD) | 165 (9.99) | 177 (9.29) | 168 (8.63) |
BMI, kg/m2, M (SD) | 25.7 (3.80) | 28.7 (4.10) | 28.6 (3.75) |
Hb, g/L, M (SD) | 140 (9.93) | 137 (23.0) | 143 (15.0) |
Creat., mcmol/L, M (SD) | 84.5 (16.7) | 77.9 (23.9) | 80.7 (13.8) |
Albumin, g/L, M (SD) | 40.8 (3.26) | 40.0 (2.16) | 41.7 (3.29) |
Charleston index, Md [Q1; Q3] | 4.00 [3.00;5.00] | 3.00 [2.00;4.00] | 3.00 [1.00;4.00] |
Duration of surgery, Md [Q1; Q3], min | 80.0 [70.0;90.0] | 80.0 [68.8;90.0] | 80.0 [67.5;87. |
Hospital stay, days, Md [Q1; Q3] | 7.00 [6.00;8.00] | 6.00 [4.00;7.00] | 5.00 [4.00;6.50] |
Blood loss, mL, M (SD) | 341 (110) | 366 (133) | 413 (182) |